SEC Form 4 · accession 0000899243-18-002691
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia J Ladd
Officer — General Counsel
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 6:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $54.05 | Feb 1, 2018 | A | 120,000 | A | — | Jan 31, 2028 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F11/4th of the underlying shares shall vest on January 16, 2019; thereafter, the shares subject to this option shall vest and become exercisable in 36 equal monthly installments with the first installment on February 16, 2019, such that this option is fully exercisable on January 16, 2022. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan).